Clinical studies recruiting near Hobart

Studies with at least one listed site matching this location on the public registry. Each page explains the study in plain language, with locations and study-team contacts. Clinicians: generate a printable list for your patient →

Precision Medicine for Every Child With Cancer
Phase N/A · Royal Hobart Hospital · Australian & New Zealand Children's Haematology/Oncology Gro · NCT05504772 IKS03 in Patients With Advanced B Cell Non-Hodgkin Lymphomas
Phase 1 · Royal Hobart Hospital · Iksuda Therapeutics Ltd. · NCT05365659 Testing the Addition of High Dose, Targeted Radiation to the Usual Treatment for Locally-Advanced Inoperable Non-Small C
Phase 3 · Northwest Cancer Center - Hobart · NRG Oncology · NCT05624996 A Study Evaluating the Efficacy and Safety of Divarasib and Pembrolizumab Versus Pembrolizumab and Pemetrexed and Carbop
Phase 3 · Royal Hobart Hospital · Hoffmann-La Roche · NCT06793215 A Global Phase III Study of Rilvegostomig or Pembrolizumab Monotherapy for First-Line Treatment of PD-L1-high Metastatic
Phase 3 · Research Site · AstraZeneca · NCT06868277 A Study to Learn About the Study Medicine Called PF-08046054/SGN-PDL1V Versus Docetaxel in Adult Participants With Previ
Phase 3 · Royal Hobart Hospital · Pfizer · NCT07144280 Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease
Phase 2/Phase 3 · Northwest Cancer Center - Hobart · NRG Oncology · NCT05174169 Post-Market Clinical Follow Up Study With Navitor Valve
Phase N/A · Royal Hobart Hospital · Abbott Medical Devices · NCT06008080 ShortStop-HER2: 12 Months vs. 6 Months of HER2-targeted Medications for People With HER2+ Breast Cancer Who Had a Pathol
Phase 3 · Northwest Cancer Center - Hobart · Alliance for Clinical Trials in Oncology · NCT06876714 PERCEIVE-Outreach: A Scalable, Risk-Based Model for Managing Persistent Cardiovascular Impact in Long COVID
NA · Menzies Insititute for Medical Research · University of Tasmania · NCT07661862 Soquelitinib vs Standard of Care in Participants With Relapsed/Refractory Peripheral T-cell Lymphoma Not Otherwise Speci
Phase 3 · Royal Hobart Hospital · Corvus Pharmaceuticals, Inc. · NCT06561048 Long-term Outcomes of Lidocaine Infusions for Post-Operative Pain (LOLIPOP) Trial
Phase 3 · Royal Hobart Hospital · Monash University · NCT05072314 Testing the Addition of Herceptin Hylecta or Phesgo to the Usual Chemotherapy for HER2 Positive Endometrial Serous Carci
Phase 3 · Northwest Cancer Center - Hobart · National Cancer Institute (NCI) · NCT05256225 A Research Study Comparing CDR132L With Placebo on the Structure and Function of the Heart in People With Heart Failure
Phase 2 · Royal Hobart Hospital · Novo Nordisk A/S · NCT06979375 Project: Every Child for Younger Patients With Cancer
Phase N/A · Royal Hobart Hospital · Children's Oncology Group · NCT02402244 A Study to Assess Adverse Events and Change in Disease Activity of Intravenous (IV) Telisotuzumab Adizutecan, Monotherap
Phase 2/Phase 3 · Icon Cancer Centre Hobart /ID# 277549 · AbbVie · NCT07155187 Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult
Phase 3 · Icon Cancer Centre Hobart · Pfizer · NCT07222800 De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Eq
Phase 3 · Northwest Cancer Center - Hobart · NRG Oncology · NCT04852887 A Randomized, Multicenter, Phase III Trial Comparing Treatment With R-mini-CHOP With R-mini-CHP + Polatuzumab Vedotin in
Phase 3 · Royal Hobart Hospital · Nordic Lymphoma Group · NCT04332822 mFOLFIRINOX Versus mFOLFOX With or Without Nivolumab for the Treatment of Advanced, Unresectable, or Metastatic HER2 Neg
Phase 3 · Northwest Cancer Center - Hobart · Alliance for Clinical Trials in Oncology · NCT05677490 Study of REGN13335 in Adult Participants With Pulmonary Arterial Hypertension (PAH)
Phase 2 · Royal Hobart Hospital · Regeneron Pharmaceuticals · NCT07318597 The Early Valve Replacement in Severe ASYmptomatic Aortic Stenosis Study
NA · Royal Hobart Hospital · University of Leicester · NCT04204915 Adding an Immunotherapy Drug, MEDI4736 (Durvalumab), to the Usual Chemotherapy Treatment (Paclitaxel, Cyclophosphamide,
Phase 3 · Northwest Cancer Center - Hobart · National Cancer Institute (NCI) · NCT06058377 A Study to Learn About the Medicine Ponsegromab in Adults With Cancer of the Pancreas Which Has Spread and Caused Signif
Phase 2/Phase 3 · Icon Cancer Centre Hobart · Pfizer · NCT06989437 TAS Test: Online Motor-cognitive Tests for Early Detection of Alzheimer's Disease
Phase N/A · University of Tasmania · University of Tasmania · NCT05194787 FLudrocortisone Administration in Aneurysmal Subarachnoid Haemorrhage
Phase 2 · Royal Hobart Hospital · The George Institute · NCT06409364 A Study to Evaluate the Benefit of Adding Durvalumab After Chemotherapy, Durvalumab and Surgery in Patients With Early-s
Phase 3 · Royal Hobart Hospital · ETOP IBCSG Partners Foundation · NCT06284317 Five or Ten Year Colonoscopy for 1-2 Non-Advanced Adenomatous Polyps
NA · Northwest Cancer Center - Hobart · NRG Oncology · NCT05080673 Tiragolumab and Atezolizumab in Advanced Pan-cancer Patients
Phase 2 · Royal Hobart Hospital · Omico · NCT06003621 Jack Jumper Ant Venom Immunotherapy Long-term Effectiveness Investigation
Phase 4 · Royal Hobart Hospital · Murdoch Childrens Research Institute · NCT06935890

Look up another city

Look up another condition